methotrexate

Poland

Drugs containing this active substance

  • METHOFILL

    The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The drug is used in the treatment of active rheumatoid arthritis in adults, severe psoriasis (especially the plaque type), active psoriatic arthritis in adults, and acute lymphoblastic leukemia in adults, adolescents, and children over 3 years of age.

    Form: tablets

    Active substance Dosage
    methotrexate 2.5 mg

    ATC: L04AX03

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used in the treatment of active rheumatoid arthritis in adults, severe psoriasis (especially the plaque type), active psoriatic arthritis in adults, and acute lymphoblastic leukemia in adults, adolescents, and children over 3 years of age.

    Form: tablets

    Active substance Dosage
    methotrexate 10 mg

    ATC: L04AX03

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriatic arthritis in adults, severe psoriasis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicinal product is used in the treatment of rheumatoid arthritis in adults, juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50.00 mg

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicinal product is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriatic arthritis, severe psoriasis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis (in children and adolescents under 16 years of age), severe psoriatic arthritis in adults, severe psoriasis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 17.5 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriatic arthritis, severe psoriasis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The drug is used in the treatment of rheumatoid arthritis in adults, juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriatic arthritis, severe psoriasis resistant to other treatments, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriatic arthritis in adults, severe psoriasis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease in adults.

    Form: solution for injection in a syringe

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in the treatment of various types of cancers, such as: acute lymphoblastic leukemia, non-Hodgkin lymphomas, osteosarcoma, advanced breast cancer, head and neck cancer (with metastasis or recurrence), choriocarcinoma and other trophoblastic diseases, and advanced bladder cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    methotrexate 100 mg/ml

    ATC: L01BA01

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used in combination therapy for malignant tumors and acute leukemias. It is also used in the treatment of severe, treatment-resistant forms of psoriasis (including psoriatic arthritis) and in other autoimmune diseases, such as rheumatoid arthritis.

    Form: tablets

    Active substance Dosage
    methotrexate 2.5 mg

    ATC: L01BA01

    Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH

  • The medicine is used to treat severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis in children and adolescents, as well as severe psoriasis resistant to treatment and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 7.5 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicine is used to treat severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis involving five or more joints in children and adolescents, as well as severe psoriasis resistant to treatment and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 10 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicine is used to treat severe active rheumatoid arthritis in adults, severe juvenile idiopathic arthritis in children and adolescents (when anti-inflammatory drugs are ineffective), as well as severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 12.5 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicine is used to treat severe active rheumatoid arthritis in adults, severe juvenile idiopathic arthritis (in patients for whom NSAIDs are ineffective), as well as severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 15 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicine is used to treat severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis involving five or more joints in children and adolescents, as well as severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 17.5 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicinal product is used for the treatment of severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis in children and adolescents, as well as for the treatment of severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 20 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicinal product is used to treat severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis in children and adolescents, as well as the treatment of severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 22.5 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicinal product is used for the treatment of severe active rheumatoid arthritis in adults, severe active juvenile idiopathic arthritis (in patients for whom NSAIDs are not sufficiently effective), as well as for the treatment of severe, treatment-resistant psoriasis and severe psoriatic arthritis in adults.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 25 mg

    ATC: L04AX03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicinal product is used in the treatment of malignant tumors (including leukemias, lymphomas, breast cancer, ovarian cancer, lung cancer, bone sarcomas) and in severe forms of psoriasis that do not respond to other treatment methods.

    Form: solution for injection

    Active substance Dosage
    methotrexate 10 mg

    ATC: L01BA01

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH

  • The medicinal product is used in the treatment of malignant tumors (e.g., leukemia, breast cancer, ovarian cancer, head and neck cancers, bone sarcomas) and in the treatment of severe forms of psoriasis that do not respond to other methods.

    Form: solution for infusion, concentrate

    Active substance Dosage
    methotrexate 100 mg/ml

    ATC: L01BA01

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH

  • The medicinal product is used in combination therapy for malignant tumors and acute leukemias. It is also used in the treatment of severe, treatment-resistant psoriasis (including psoriatic arthritis) and in other autoimmune diseases, such as rheumatoid arthritis.

    Form: tablets

    Active substance Dosage
    methotrexate 5 mg

    ATC: L01BA01

    Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH

  • The medicinal product is used in combination therapy for many cancers and acute leukemias. It is also used in the treatment of severe, treatment-resistant psoriasis (including psoriatic arthritis) and in other autoimmune diseases, such as rheumatoid arthritis.

    Form: tablets

    Active substance Dosage
    methotrexate 10 mg

    ATC: L01BA01

    Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH

  • The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 15 mg

    ATC: L04AX03

    Manufacturer: Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

  • The medicinal product is used in the treatment of active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 20 mg

    ATC: L04AX03

    Manufacturer: Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

  • This medicine is used to treat active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 25 mg

    ATC: L04AX03

    Manufacturer: Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

  • The medicine is used in the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease (mild to moderate course).

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 7.5 mg

    ATC: L04AX03

    Manufacturer: Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

  • The medicine is used in the treatment of rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 10 mg

    ATC: L04AX03

    Manufacturer: Biomedica Foscama Industria Chimico-Farmaceutica S.p.a. S.C. Sindan-Pharma S.R.L.

  • The medicine is used to treat rheumatoid arthritis in adults, severe psoriasis resistant to other treatments, severe psoriatic arthritis in adults, and for maintenance treatment of acute lymphoblastic leukemia in adults, adolescents, and children over 3 years of age.

    Form: tablets

    Active substance Dosage
    methotrexate 2.5 mg

    ATC: L01BA01 L04AX03

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used to treat active rheumatoid arthritis in adults, severe psoriasis in adults that is resistant to other treatments, severe psoriatic arthritis in adults, and for the maintenance treatment of acute lymphoblastic leukemia in adults, adolescents, and children over 3 years of age.

    Form: tablets

    Active substance Dosage
    methotrexate 10 mg

    ATC: L01BA01

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicinal product is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used in the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.

  • The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis (including psoriatic arthritis), and mild to moderate Crohn's disease.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    methotrexate 37.5 mg/ml

    ATC: L04AX03

    Manufacturer: Basic Pharma Manufacturing B.V.